Yatender Kumar

Responsive image
  • Profile
  • QualificationsB.Tech, GGSIPU, New Delhi; Ph.D, CCMB, Hyderabad; Post Doc: Max-Planck Unit, Germany
  • DesignationAssistant Professor
  • DivisionBiotechnology
  • E-Mailyatenderkumar@gmail.com; yatender.kumar@nsit.ac.in


Dr. Yatender Kumar is currently working as an Assistant Professor at Division of Biotechnology, NSIT, Dwarka Sector- 3, New Delhi and his research areas include Programmed Cell Death, Innate Immunity and Alzheimer’s disease. He did his PhD from Centre for Cellular and Molecular Biology, Hyderabad, INDIA in the year 2010 and post doc from Max-Planck Unit for Structural and Molecular Biology, Hamburg and DZNE, Bonn, Germany where he received prestigious Max-Planck fellowship awarded by the Max-Planck Society. Later, he joined Premas Biotech Pvt. Ltd., Gurgaon as Research Scientist where he worked on development of cell-based screening assays; cloning, expression and purification of antibodies. He got associated with NSIT as an Assistant Professor in Division of Biotechnology from 1st October 2014.

Subjects Taught-

Biochemistry, Microbiology, Methods & Instrumentation in Biotechnology, Recombinant DNA Technology, Current Topics in Biotechnology, Advance Genetic Engineering

Areas of Interest

Cell and Molecular Biology

Recombinant DNA Technology

Honours and Awards
  • Early Career Research Award 2016 from Science & Engineering Research Board (SERB), Department of Science and Technology, Government of India.
  • Max-Planck Institute Research Fellowship, Germany (Jan 2011- Mar 2013).
  • Guest Scientist Fellowship from Institute of Experimental Internal Medicine, 39120 Magdeburg, Germany (Aug-Sep 2010)
  • Awarded 1st Prizefor "Dr K. V. Rao Research Award" for the year 2010 in Biological Sciences, held on 3rd April 2010, Jubilee Hills, Hyderabad, India.
  • Senior Research Fellowship by Council of Scientific and Industrial Research, Govt. of India(2006-2009).
  • Junior Research Fellowship by Council of Scientific and Industrial Research, Govt. of India(2004-2006).
  • Graduate Aptitude Test in Engineering (GATE) - Qualified in the year 2004 with 88 percentile (All India Rank 55).
  • 3rdRank in All India Common Entrance Test for B.Tech in Biotechnology programme of Guru Gobind Singh IndraPrastha University (GGSIPU), New Delhi (2000) and awarded scholarship.
  • Poster presentation inBESCON – 2017, "Biological Engineering in 21st Century" at NSIT, September 8 - 9, (2017).
  • Participated in one-week Short Term Course on “Accreditation of Programmes’ organized by CDC at NITTTR, Chandigarh, from 5-9 June, 2017.
  • Participated in one-week Short Term Course on “Artificial Intelligence in Engineering Applications”held at NSIT during 26th - 30th December 2016.
  • Participated in Workshop on “IPR Awareness”held on 22nd and 23rd January 2016 at NSIT.
  • Participated in Workshop on “Moodle: An Online Learning Management System”held on 13th and 14th July 2015 in ICE Division, NSIT.
  • Oral Presentation at “11th International Conference On Alzheimer’s & Parkinson’s Diseases AD/PD 2013”Florence, Italy, March 6-10 (2013).
  • Participated in 1st Microscopy Workshop “Zeiss on Your Campus at DZNE”Bonn, Germany, Dec 5-6 (2012).
  • Participated in 2ndAnnual Gladstone/DZNE workshop on ‘Synaptic Pathophysiology and Neurodegenerative Disease’, Bonn, Germany, May 16-18 (2012).
  • Oral Presentation at Annual DZNE Unit Science Meeting on “Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration”, Bonn, Germany, 23rdMarch, (2012).
  • Participated in “DZNE AND MPI CONFERENCE ON AGEING AND NEURODEGENERATION”, Bergisch Gladbach, Germany, September 1-4 (2011).
  • Oral Presentation in “XXXII All India Cell Biology Conference & Symposium on Stem Cells and Pattern Formation”, Agharkar Research Institute, Pune, India, December 4-6 (2008).
  • Participated in “International Symposium on Translational Research: Apoptosis & Cancer”, Trivandrum, India, December 18-21 (2005).
  • Participated in “1stAnnual International Conference on Translational Research B2B-2K5 for Cancer and Other Diseases”, CCMB, Hyderabad, India, March 19-20 (2005).
  • Participated in symposia on “Highlighting principal activities of Indian Biotechnology Industry in the second Indo - Asian Business meet”, organized by All India Biotech Association (AIBA), New Delhi, India, September (2003).
  • Zempel H, Dennissen F, Kumar Y, Luedtke J, Biernat J, Mandelkow EM, Mandelkow EAxondendritic sorting and pathological missorting of Tau is isoform specific and determined by axon initial segment architecture. J Biol Chem. (2017) 292(29): 12192-12207.
  • Raghawan AK, Sripada A, Gopinath G, Pushpanjali P, Kumar Y, Radha V, Swarup GA Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death. J Biol Chem. (2017) Vol 292(4): 1218-1230.
  • Mandelkow EM, Sydow A, Hochgrafe K, Kumar Y, Zempel H, Mandelkow E. Tau, axonal transport and Alzheimer's disease. European Neuropsychopharmacology (2013) Vol 23: S115-S116.
  • Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E, Mandelkow EM. Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. (2013) Vol 32(22), 2920-2937.
  • Li X, Kumar Y, Zempel H, Mandelkow EM, Biernat J, Mandelkow E. Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegenerationEMBO J. (2011) Vol 30(23), 4825-4837.                                                                                                                    
  • Kumar Y, Radha V, Swarup G. Interaction with Sug1 enables Ipaf ubiquitination leading to caspase-8 activation and cell death. J. (2010) Vol 427(1), 91-104.
  • Kumar Y,Radha V, Swarup G. CASP1 (caspase 1, apoptosis related cysteine peptidase (interleukin 1, beta, convertase)). Atlas Genet Cytogenet Oncol Haematol. (2008)Vo12(4), 269-275.
  • Kumar Y, Radha V, Swarup G. NLRC4 (NLR Family, CARD domain containing 4). Atlas Genet Cytogenet Oncol Haematol. (2008)Vo12(1), 56-58.